ReviewThe Canadian journal of urology2025
Patient reported outcome measures: their evolution and expansion in urology.
Review in The Canadian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Democratization of the anatomical endoscopic enucleation of the prostate with bipolar energy].Revista medica del Instituto Mexicano del Seguro Social · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe the history of Patient-Reported Outcome Measures (PROMs) in medicine, with a focus on the development and use of the International Index of Erectile Function (IIEF) in urologic practice. PROMs emerged in the 1970s with tools like the Sickness Impact Profile, designed to capture patients' perspectives on how disease affects daily life. In the 1990s, PROMs entered urology with the creation of the International Prostate Symptom Score (IPSS) and the IIEF, developed in 1992 and 1997, respectively. As organizations such as the National Institutes of Health began prioritizing PROMs for evaluating sexual function, the IIEF gained recognition as a valid and reliable measure of erectile dysfunction severity. The introduction of the abbreviated IIEF-5 further expanded its use in both research and clinical practice. For this review, we searched PubMed for literature on the history, development, and application of PROMs and the IIEF, and conducted an oral interview with Dr. Raymond C. Rosen, the IIEF's primary author. In conclusion, PROMs have long served as essential tools for capturing patients' experiences, and the IIEF has significantly advanced sexual medicine by offering a highly valid and reliable instrument for assessing erectile dysfunction.
Indexed as
Identifiers
41496531What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.